Skip to content
GLP-1 Savers
Menu
Ranked #417 · Watch List

NowPatient review

NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $1,069/mo

From $1,069/mo (brand Mounjaro, promotional rate)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a single-tier rate, not a price that is guaranteed at every dose, and the price is not shown until after you complete an intake.

How much does NowPatient cost?

The price NowPatient publishes is From $1,069/mo (brand Mounjaro, promotional rate). Compounded semaglutide is listed at From $1,349/mo (brand Wegovy). We flag this one to watch: confirm the ongoing rate with NowPatient before you count on it, because a low first month can step up afterward.

Semaglutide
From $1,349/mo (brand Wegovy)
Tirzepatide
From $1,069/mo (brand Mounjaro, promotional rate)
Coverage
Coverage not published
Brand-name
Yes

The Value Score card

NowPatient scored on our six published factors. See the methodology.

Lowest Real Price20/100
No Teaser-Rate Bait38/100
Nationwide Availability45/100
Both Molecules98/100
Easy Cancellation58/100
Reputation80/100

Why it's a deal

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Read the fine print

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

The bottom line

Best for: Shoppers who want brand-name GLP-1 access without a compounded route. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

Ranked #417 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to NowPatient, out of 426 others we track.

Shopping NowPatient against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs NowPatient, and every program that undercuts or outscores it — starting with Concierge MD LA, the closest match on score — is ranked on the NowPatient alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from NowPatient's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on NowPatient's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals